Policy / Pricing US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028 Pharmaceutical TechnologyIf introduced, the 100% tariffs would apply to all generic drugs imported to the US, which make up 90% of the nation's prescriptions.Read full story pharminent July 22, 2026 (Last updated: July 22, 2026) Pharmaceutical Technology If introduced, the 100% tariffs would apply to all generic drugs imported to the US, which make up 90% of the nation’s prescriptions. Read full story Post navigation Previous: Cellares and Papillon partner for PPL-001 manufacturing automationNext: Repligen builds in cell therapy with $1.5bn BioLife takeover Related Stories Policy / Pricing Mid-cap biotechs join Trump’s latest round of drug pricing deals pharminent September 1, 2026 Policy / Pricing MFN sparks defiance from Europe’s larger nations, uncertainty among smaller ones pharminent August 27, 2026 Policy / Pricing MFN affecting Swiss medicines access, says Interpharma pharminent August 13, 2026